OST-4077

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameOST-4077
Drug Alias NameOST-4077
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A